Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) This number includes shares held by The Lebowitz Family Stock, LLC, a limited liability company of which Steven D. Lebowitz is the sole manager. (3) This number includes shares held by (a) Deborah P. Lebowitz, (b) The Steven & Deborah Lebowitz Foundation (the "Foundation"), a trust over which Steven D. Lebowitz serves as a co-trustee and (c) the Lebowitz Family Trust - 1986, dated October 7, 1986, as amended (the "LF Trust"), a trust over which Steven D. Lebowitz serves as a co-trustee, (d) Kora Miri Silverberg 2021 Irrevocable Trust, and (e) Isla Silverberg 2020 Irrevocable Trust. (4) This number includes shares held by (a) Lauren Lebowitz Salem, (b) Robert Lebowitz, (c) Kathryn Lebowitz Silverberg, (d) the A&A Lebowitz Trust (the "AA Trust"), (e) Susan Pearlstein, and (f) and Clinton Paul. (5) Based on 116,294,461 shares of common stock of FTAI Infrastructure Inc. (the "Issuer") outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) This number includes shares held by (a) the Foundation, a trust over which Deborah P. Lebowitz serves as a co-trustee, (b) the LF Trust, a trust over which Deborah P. Lebowitz serves as a co-trustee, (c) Kora Miri Silverberg 2021 Irrevocable Trust, and (d) Isla Silverberg 2020 Irrevocable Trust. (3) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) This number includes shares held by the AA Trust, a trust over which Andrew Lebowitz serves as a co-trustee. (3) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) This number includes shares held by the AA Trust, a trust over which Ashley Lebowitz serves as a co-trustee. (3) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:   (1) The number of shares reported as beneficially owned as of December 31, 2025. (2) Based on 116,294,461 shares of common stock of the Issuer outstanding as of December 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission on October 31, 2025.


SCHEDULE 13G



 
Steven D. Lebowitz
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:By: Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Deborah P. Lebowitz
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Lauren Lebowitz Salem
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Robert Lebowitz
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Kathryn Lebowitz Silverberg
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Andrew Lebowitz
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Ashley Lebowitz
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
The Lebowitz Family Stock, LLC
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Debra Paul
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Susan Pearlstein
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Kora Miri Silverberg
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
 
Isla Silverberg
 
Signature:/s/ Andrew Collins,Attorney in Fact
Name/Title:Andrew Collins, Attorney-In-Fact
Date:02/12/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement Exhibit 99.2 Item 8 Statement Exhibit 99.3 Power of Attorney